Joseph L. Kelley III, MD
M.D.
Magee-Womens Hospital of UPMC
300 Halket Street
Pittsburgh,
PA
USA
15213
Papers:
132
Therapeutic benefit of lymphadenectomy in low grade epithelial ovarian carcinoma: a national cancer database study
145
Platinum and taxane-induced ovarian toxicity: mechanism of damage and evaluation of gonadoprotective agents
232
Surgical outcomes of patients undergoing extrafascial hysterectomy following neoadjuvant high-dose rate brachytherapy for locally advanced endometrial cancer clinically extending to the cervix or parametria
289
Neoadjuvant chemotherapy reduces operative morbidity without effecting time to recurrence in advanced stage epithelial ovarian cancer
290
Time to chemotherapy following surgical cytoreduction for epithelial ovarian cancer: does neoadjuvant chemotherapy make a difference?
326
A novel orthotopic mouse model of epithelial ovarian carcinoma demonstrating progression from early stage disease to carcinomatosis in both immune-competent and immune-deficient models
410
Small cell neuroendocrine carcinoma of the cervix: does treatment sequence and type of hysterectomy improve outcomes?
457
Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancers: is there a role?
487
Improvement in symptom burden within one day after palliative care consultation in a cohort of gynecologic oncology inpatients